Theratechnologies Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Theratechnologies Inc. with three other
companies in this sector in Canada:
Acerus Pharmaceuticals Corporation
sales of 32.35 million Canadian Dollars [US$25.84 million]
Cardiome Pharma Corp.
(33.37 million Canadian Dollars [US$26.65 million]
of which 100%
was Pharma Product Development), and
Nuvo Pharmaceuticals Inc
(27.04 million Canadian Dollars [US$21.60 million]
During the year ended November of 2016, sales at
Theratechnologies Inc. were C$37.07 million (US$29.61 million).
increase of 23.3%
versus 2015, when the company's sales were C$30.06 million.